BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han NR, Kim YK, Ahn S, Hwang TY, Lee H, Park HJ. A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid. Front Aging Neurosci 2020;12:599045. [PMID: 33519420 DOI: 10.3389/fnagi.2020.599045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nielsen SD, Pearson NM, Seidler K. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport. Brain Res 2021;1769:147609. [PMID: 34371014 DOI: 10.1016/j.brainres.2021.147609] [Reference Citation Analysis]
2 Lama J, Buhidma Y, Fletcher E, Duty S. Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research. Neuronal Signaling 2021;5:NS20210026. [DOI: 10.1042/ns20210026] [Reference Citation Analysis]
3 Van Den Berge N, Ulusoy A. Animal models of brain-first and body-first Parkinson's disease. Neurobiology of Disease 2022;163:105599. [DOI: 10.1016/j.nbd.2021.105599] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
4 Decourt M, Jiménez-Urbieta H, Benoit-Marand M, Fernagut PO. Neuropsychiatric and Cognitive Deficits in Parkinson's Disease and Their Modeling in Rodents. Biomedicines 2021;9:684. [PMID: 34204380 DOI: 10.3390/biomedicines9060684] [Reference Citation Analysis]
5 Fan Y, Han J, Zhao L, Wu C, Wu P, Huang Z, Hao X, Ji Y, Chen D, Zhu M. Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal. Front Aging Neurosci 2021;13:745438. [PMID: 34912207 DOI: 10.3389/fnagi.2021.745438] [Reference Citation Analysis]
6 Oh J, Lee Y, Hwang T, Cho S, Jang J, Ryu Y, Park H. Acupuncture Regulates Symptoms of Parkinson’s Disease via Brain Neural Activity and Functional Connectivity in Mice. Front Aging Neurosci 2022;14:885396. [DOI: 10.3389/fnagi.2022.885396] [Reference Citation Analysis]
7 Haque ME, Azam S, Akther M, Cho DY, Kim IS, Choi DK. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease. Int J Mol Sci 2021;22:4674. [PMID: 33925146 DOI: 10.3390/ijms22094674] [Reference Citation Analysis]
8 Su Y, Liu N, Zhang Z, Hao L, Ma J, Yuan Y, Shi M, Liu J, Zhao Z, Zhang Z, Holscher C. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175029] [Reference Citation Analysis]